Literature DB >> 1123430

Effects of the 15-methyl analogs of prostaglandins E2 and F2alpha on the pulmonary circulation in the intact dog.

P J Kadowitz, P D Joiner, C S Matthews, A L Hyman.   

Abstract

The effects of the 15-methul analogs of prostaglandins E2 (PGE2) and F2alpha (PGF2alpha) on the pulmonary circulation were studied in the intact dog under conditions of controlled blood flow. Infusions of either analog into the lobar artery increased lobar arterial pressure by more than 100 per cent. The rise in lobar arterial pressure was accompanied by a rise in lobar venous pressure and in pressure gradient from lobar artery to small vein but no change in pressure in the left atrium. The methyl analogs were about 10 times more potent than PGE2 and PGF2alpha in elevating pulmonary vascular resistance in the dog. The effects of the analogs on the pulmonary vascular bed were similar in experiments in which the lung was perfused with dextran or with blood. Both analogs contracted isolated helical segments of canine intrapulmonary artery and vein in a dose-related manner. In other experiments the effects of passive increases in venous pressure produced by distension of a balloon catheter in the lobar vein were contrasted with the action of the analogs on the pulmonary vascular bed. Balloon distension increased pressure in the lobar artery and small vein but had no effect on pressure in the left atrium. However, in contrast to the increase in gradient with the analogs, balloon distension decreased the pressure gradient from lobar artery to small vein. Results of the present study indicate that the prostaglandin analogs increase pulmonary vascular resistance by actively contricting pulmonary veins and vessels upstream to small veins, presumed to be small arteries. It is concluded that the analogs are potent pressor substances in the pulmonary circulation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1123430      PMCID: PMC301839          DOI: 10.1172/JCI108023

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  ACTIVE AND PASSIVE COMPONENTS OF PULMONARY VASCULAR RESPONSE TO VASOACTIVE DRUGS IN THE DOG.

Authors:  J W FEELEY; T D LEE; W R MILNOR
Journal:  Am J Physiol       Date:  1963-12

2.  THE EFFECTS OF ACUTE HYPOXIA ON PRESSURE, FLOW, AND RESISTANCE IN THE PULMONARY VASCULAR BED.

Authors:  W B BERRY; J S MCLAUGHLIN; W D CLARK; A G MORROW
Journal:  Surgery       Date:  1965-08       Impact factor: 3.982

3.  Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema.

Authors:  A C GUYTON; A W LINDSEY
Journal:  Circ Res       Date:  1959-07       Impact factor: 17.367

4.  Action of hypoxia on the pulmonary vasculature.

Authors:  C RIVERA-ESTRADA; P W SALTZMAN; D SINGER; L N KATZ
Journal:  Circ Res       Date:  1958-01       Impact factor: 17.367

Review 5.  The lung in relation to vasoactive hormones.

Authors:  S I Said
Journal:  Fed Proc       Date:  1973-09

Review 6.  Prostaglandins.

Authors:  J R Weeks
Journal:  Annu Rev Pharmacol       Date:  1972       Impact factor: 13.820

7.  Intrauterine administration of 15 (S)-15-methyl-prostaglandin F 2 for induction of abortion.

Authors:  M Bygdeman; F Béguin; M Toppozada; N Wiqvist; S Bergström
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

8.  Influence of the prostaglandins E1 and E2 on aggregation of blood platelets.

Authors:  S Van Creveld; C N Pascha
Journal:  Nature       Date:  1968-04-27       Impact factor: 49.962

9.  Metabolism of prostaglandin E 2 in guinea pig liver.

Authors:  M Hamberg; U Israelsson; B Samuelsson
Journal:  Ann N Y Acad Sci       Date:  1971-04-30       Impact factor: 5.691

10.  Selective passage of prostaglandins across the lung.

Authors:  J C McGiff; N A Terragno; J C Strand; J B Lee; A J Lonigro; K K Ng
Journal:  Nature       Date:  1969-08-16       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.